Global BCG and Tuberculosis Vaccine Market Research Report 2026(Status and Outlook)

May 2026 | 151 pages | ID: G9C4A62213A2EN
Bosson Research

Abstracts

Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Gu?rin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.The tuberculosis (TB) vaccination market is driven by the global efforts to combat TB and the increasing burden of the disease in high-risk populations. TB is a highly contagious bacterial infection that poses a significant public health challenge worldwide. Vaccination against TB, primarily through the Bacille Calmette-Gu?rin (BCG) vaccine, is essential in reducing TB incidence and severity, especially in endemic regions. The rise in TB cases and drug-resistant strains contribute to market growth as governments and healthcare organizations focus on prevention strategies. Moreover, advancements in vaccine research and development, including novel TB vaccines under investigation, have the potential to further improve TB control efforts. However, the market also faces challenges, including the variable efficacy of the BCG vaccine against different forms of TB and the need for improved vaccine coverage in high-burden areas. Additionally, addressing vaccine supply and distribution challenges and ensuring equitable access to TB vaccination can pose obstacles for comprehensive disease control. To succeed, companies must focus on research and development to offer innovative TB vaccine candidates, collaborate with global health initiatives to promote vaccination campaigns, and address the challenges to meet the increasing demand for effective TB prevention solutions.

The global BCG and Tuberculosis Vaccine market size was estimated at USD 78.2 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.00% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global BCG and Tuberculosis Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global BCG and Tuberculosis Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the BCG and Tuberculosis Vaccine market.

Global BCG and Tuberculosis Vaccine Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• Merck
• Japan BCG Lab
• Serum Institute of India
• AJ Vaccines
• BioFarma
• GreenSignal Bio Pharma
• China National Biotec
• Biomed Lublin
• Taj Pharmaceuticals
• Ataulpho de Paiva
• IVAC-Institute of Vaccines and Medical Biologicals
• Queen Saovabha Mem. Inst
• Microgen

Market Segmentation (by Type)

• Immune Vaccine
• Therapy Vaccine

Market Segmentation (by Application)

• Self-Procurement
• UNICEF
• Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the BCG and Tuberculosis Vaccine Market

Overview of the regional outlook of the BCG and Tuberculosis Vaccine Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the BCG and Tuberculosis Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of BCG and Tuberculosis Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of BCG and Tuberculosis Vaccine
1.2 Key Market Segments
  1.2.1 BCG and Tuberculosis Vaccine Segment by Type
  1.2.2 BCG and Tuberculosis Vaccine Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 BCG AND TUBERCULOSIS VACCINE MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global BCG and Tuberculosis Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global BCG and Tuberculosis Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 BCG AND TUBERCULOSIS VACCINE MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global BCG and Tuberculosis Vaccine Product Life Cycle
3.3 Global BCG and Tuberculosis Vaccine Sales by Manufacturers (2020-2025)
3.4 Global BCG and Tuberculosis Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 BCG and Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global BCG and Tuberculosis Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 BCG and Tuberculosis Vaccine Market Competitive Situation and Trends
  3.8.1 BCG and Tuberculosis Vaccine Market Concentration Rate
  3.8.2 Global 5 and 10 Largest BCG and Tuberculosis Vaccine Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 BCG AND TUBERCULOSIS VACCINE INDUSTRY CHAIN ANALYSIS

4.1 BCG and Tuberculosis Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF BCG AND TUBERCULOSIS VACCINE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global BCG and Tuberculosis Vaccine Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to BCG and Tuberculosis Vaccine Market
5.7 ESG Ratings of Leading Companies

6 BCG AND TUBERCULOSIS VACCINE MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global BCG and Tuberculosis Vaccine Sales Market Share by Type (2020-2025)
6.3 Global BCG and Tuberculosis Vaccine Market Size by Type (2020-2025)
6.4 Global BCG and Tuberculosis Vaccine Price by Type (2020-2025)

7 BCG AND TUBERCULOSIS VACCINE MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global BCG and Tuberculosis Vaccine Market Sales by Application (2020-2025)
7.3 Global BCG and Tuberculosis Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global BCG and Tuberculosis Vaccine Sales Growth Rate by Application (2020-2025)

8 BCG AND TUBERCULOSIS VACCINE MARKET SALES BY REGION

8.1 Global BCG and Tuberculosis Vaccine Sales by Region
  8.1.1 Global BCG and Tuberculosis Vaccine Sales by Region
  8.1.2 Global BCG and Tuberculosis Vaccine Sales Market Share by Region
8.2 Global BCG and Tuberculosis Vaccine Market Size by Region
  8.2.1 Global BCG and Tuberculosis Vaccine Market Size by Region
  8.2.2 Global BCG and Tuberculosis Vaccine Market Size by Region
8.3 North America
  8.3.1 North America BCG and Tuberculosis Vaccine Sales by Country
  8.3.2 North America BCG and Tuberculosis Vaccine Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe BCG and Tuberculosis Vaccine Sales by Country
  8.4.2 Europe BCG and Tuberculosis Vaccine Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific BCG and Tuberculosis Vaccine Sales by Region
  8.5.2 Asia Pacific BCG and Tuberculosis Vaccine Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America BCG and Tuberculosis Vaccine Sales by Country
  8.6.2 South America BCG and Tuberculosis Vaccine Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa BCG and Tuberculosis Vaccine Sales by Region
  8.7.2 Middle East and Africa BCG and Tuberculosis Vaccine Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 BCG AND TUBERCULOSIS VACCINE MARKET PRODUCTION BY REGION

9.1 Global Production of BCG and Tuberculosis Vaccine by Region(2020-2025)
9.2 Global BCG and Tuberculosis Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global BCG and Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America BCG and Tuberculosis Vaccine Production
  9.4.1 North America BCG and Tuberculosis Vaccine Production Growth Rate (2020-2025)
  9.4.2 North America BCG and Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe BCG and Tuberculosis Vaccine Production
  9.5.1 Europe BCG and Tuberculosis Vaccine Production Growth Rate (2020-2025)
  9.5.2 Europe BCG and Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan BCG and Tuberculosis Vaccine Production (2020-2025)
  9.6.1 Japan BCG and Tuberculosis Vaccine Production Growth Rate (2020-2025)
  9.6.2 Japan BCG and Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China BCG and Tuberculosis Vaccine Production (2020-2025)
  9.7.1 China BCG and Tuberculosis Vaccine Production Growth Rate (2020-2025)
  9.7.2 China BCG and Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Merck
  10.1.1 Merck Basic Information
  10.1.2 Merck BCG and Tuberculosis Vaccine Product Overview
  10.1.3 Merck BCG and Tuberculosis Vaccine Product Market Performance
  10.1.4 Merck Business Overview
  10.1.5 Merck SWOT Analysis
  10.1.6 Merck Recent Developments
10.2 Japan BCG Lab
  10.2.1 Japan BCG Lab Basic Information
  10.2.2 Japan BCG Lab BCG and Tuberculosis Vaccine Product Overview
  10.2.3 Japan BCG Lab BCG and Tuberculosis Vaccine Product Market Performance
  10.2.4 Japan BCG Lab Business Overview
  10.2.5 Japan BCG Lab SWOT Analysis
  10.2.6 Japan BCG Lab Recent Developments
10.3 Serum Institute of India
  10.3.1 Serum Institute of India Basic Information
  10.3.2 Serum Institute of India BCG and Tuberculosis Vaccine Product Overview
  10.3.3 Serum Institute of India BCG and Tuberculosis Vaccine Product Market Performance
  10.3.4 Serum Institute of India Business Overview
  10.3.5 Serum Institute of India SWOT Analysis
  10.3.6 Serum Institute of India Recent Developments
10.4 AJ Vaccines
  10.4.1 AJ Vaccines Basic Information
  10.4.2 AJ Vaccines BCG and Tuberculosis Vaccine Product Overview
  10.4.3 AJ Vaccines BCG and Tuberculosis Vaccine Product Market Performance
  10.4.4 AJ Vaccines Business Overview
  10.4.5 AJ Vaccines Recent Developments
10.5 BioFarma
  10.5.1 BioFarma Basic Information
  10.5.2 BioFarma BCG and Tuberculosis Vaccine Product Overview
  10.5.3 BioFarma BCG and Tuberculosis Vaccine Product Market Performance
  10.5.4 BioFarma Business Overview
  10.5.5 BioFarma Recent Developments
10.6 GreenSignal Bio Pharma
  10.6.1 GreenSignal Bio Pharma Basic Information
  10.6.2 GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Product Overview
  10.6.3 GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Product Market Performance
  10.6.4 GreenSignal Bio Pharma Business Overview
  10.6.5 GreenSignal Bio Pharma Recent Developments
10.7 China National Biotec
  10.7.1 China National Biotec Basic Information
  10.7.2 China National Biotec BCG and Tuberculosis Vaccine Product Overview
  10.7.3 China National Biotec BCG and Tuberculosis Vaccine Product Market Performance
  10.7.4 China National Biotec Business Overview
  10.7.5 China National Biotec Recent Developments
10.8 Biomed Lublin
  10.8.1 Biomed Lublin Basic Information
  10.8.2 Biomed Lublin BCG and Tuberculosis Vaccine Product Overview
  10.8.3 Biomed Lublin BCG and Tuberculosis Vaccine Product Market Performance
  10.8.4 Biomed Lublin Business Overview
  10.8.5 Biomed Lublin Recent Developments
10.9 Taj Pharmaceuticals
  10.9.1 Taj Pharmaceuticals Basic Information
  10.9.2 Taj Pharmaceuticals BCG and Tuberculosis Vaccine Product Overview
  10.9.3 Taj Pharmaceuticals BCG and Tuberculosis Vaccine Product Market Performance
  10.9.4 Taj Pharmaceuticals Business Overview
  10.9.5 Taj Pharmaceuticals Recent Developments
10.10 Ataulpho de Paiva
  10.10.1 Ataulpho de Paiva Basic Information
  10.10.2 Ataulpho de Paiva BCG and Tuberculosis Vaccine Product Overview
  10.10.3 Ataulpho de Paiva BCG and Tuberculosis Vaccine Product Market Performance
  10.10.4 Ataulpho de Paiva Business Overview
  10.10.5 Ataulpho de Paiva Recent Developments
10.11 IVAC-Institute of Vaccines and Medical Biologicals
  10.11.1 IVAC-Institute of Vaccines and Medical Biologicals Basic Information
  10.11.2 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Product Overview
  10.11.3 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Product Market Performance
  10.11.4 IVAC-Institute of Vaccines and Medical Biologicals Business Overview
  10.11.5 IVAC-Institute of Vaccines and Medical Biologicals Recent Developments
10.12 Queen Saovabha Mem. Inst
  10.12.1 Queen Saovabha Mem. Inst Basic Information
  10.12.2 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Product Overview
  10.12.3 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Product Market Performance
  10.12.4 Queen Saovabha Mem. Inst Business Overview
  10.12.5 Queen Saovabha Mem. Inst Recent Developments
10.13 Microgen
  10.13.1 Microgen Basic Information
  10.13.2 Microgen BCG and Tuberculosis Vaccine Product Overview
  10.13.3 Microgen BCG and Tuberculosis Vaccine Product Market Performance
  10.13.4 Microgen Business Overview
  10.13.5 Microgen Recent Developments

11 BCG AND TUBERCULOSIS VACCINE MARKET FORECAST BY REGION

11.1 Global BCG and Tuberculosis Vaccine Market Size Forecast
11.2 Global BCG and Tuberculosis Vaccine Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe BCG and Tuberculosis Vaccine Market Size Forecast by Country
  11.2.3 Asia Pacific BCG and Tuberculosis Vaccine Market Size Forecast by Region
  11.2.4 South America BCG and Tuberculosis Vaccine Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of BCG and Tuberculosis Vaccine by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global BCG and Tuberculosis Vaccine Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of BCG and Tuberculosis Vaccine by Type (2026-2035)
  12.1.2 Global BCG and Tuberculosis Vaccine Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of BCG and Tuberculosis Vaccine by Type (2026-2035)
12.2 Global BCG and Tuberculosis Vaccine Market Forecast by Application (2026-2035)
  12.2.1 Global BCG and Tuberculosis Vaccine Sales (K MT) Forecast by Application
  12.2.2 Global BCG and Tuberculosis Vaccine Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global BCG and Tuberculosis Vaccine Market Size by Type (M USD)
Table 4. Global BCG and Tuberculosis Vaccine Market Size by Application
Table 5. BCG and Tuberculosis Vaccine Market Size Comparison by Region (M USD)
Table 6. Global BCG and Tuberculosis Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global BCG and Tuberculosis Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global BCG and Tuberculosis Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global BCG and Tuberculosis Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCG and Tuberculosis Vaccine as of 2025)
Table 11. Global Market BCG and Tuberculosis Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global BCG and Tuberculosis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. BCG and Tuberculosis Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global BCG and Tuberculosis Vaccine Sales by Type (K MT)
Table 27. Global BCG and Tuberculosis Vaccine Market Size by Type (M USD)
Table 28. Global BCG and Tuberculosis Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global BCG and Tuberculosis Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global BCG and Tuberculosis Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global BCG and Tuberculosis Vaccine Market Share by Type (2020-2025)
Table 32. Global BCG and Tuberculosis Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global BCG and Tuberculosis Vaccine Sales (K MT) by Application
Table 34. Global BCG and Tuberculosis Vaccine Market Size by Application
Table 35. Global BCG and Tuberculosis Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global BCG and Tuberculosis Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global BCG and Tuberculosis Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global BCG and Tuberculosis Vaccine Market Share by Application (2020-2025)
Table 39. Global BCG and Tuberculosis Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global BCG and Tuberculosis Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global BCG and Tuberculosis Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global BCG and Tuberculosis Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global BCG and Tuberculosis Vaccine Market Size by Region (2020-2025)
Table 44. North America BCG and Tuberculosis Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America BCG and Tuberculosis Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe BCG and Tuberculosis Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe BCG and Tuberculosis Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific BCG and Tuberculosis Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific BCG and Tuberculosis Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America BCG and Tuberculosis Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America BCG and Tuberculosis Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa BCG and Tuberculosis Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa BCG and Tuberculosis Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global BCG and Tuberculosis Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global BCG and Tuberculosis Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global BCG and Tuberculosis Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global BCG and Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America BCG and Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe BCG and Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan BCG and Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China BCG and Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Merck Basic Information
Table 63. Merck BCG and Tuberculosis Vaccine Product Overview
Table 64. Merck BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Merck Business Overview
Table 66. Merck SWOT Analysis
Table 67. Merck Recent Developments
Table 68. Japan BCG Lab Basic Information
Table 69. Japan BCG Lab BCG and Tuberculosis Vaccine Product Overview
Table 70. Japan BCG Lab BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Japan BCG Lab Business Overview
Table 72. Japan BCG Lab SWOT Analysis
Table 73. Japan BCG Lab Recent Developments
Table 74. Serum Institute of India Basic Information
Table 75. Serum Institute of India BCG and Tuberculosis Vaccine Product Overview
Table 76. Serum Institute of India BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Serum Institute of India Business Overview
Table 78. Serum Institute of India SWOT Analysis
Table 79. Serum Institute of India Recent Developments
Table 80. AJ Vaccines Basic Information
Table 81. AJ Vaccines BCG and Tuberculosis Vaccine Product Overview
Table 82. AJ Vaccines BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. AJ Vaccines Business Overview
Table 84. AJ Vaccines Recent Developments
Table 85. BioFarma Basic Information
Table 86. BioFarma BCG and Tuberculosis Vaccine Product Overview
Table 87. BioFarma BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. BioFarma Business Overview
Table 89. BioFarma Recent Developments
Table 90. GreenSignal Bio Pharma Basic Information
Table 91. GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Product Overview
Table 92. GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. GreenSignal Bio Pharma Business Overview
Table 94. GreenSignal Bio Pharma Recent Developments
Table 95. China National Biotec Basic Information
Table 96. China National Biotec BCG and Tuberculosis Vaccine Product Overview
Table 97. China National Biotec BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. China National Biotec Business Overview
Table 99. China National Biotec Recent Developments
Table 100. Biomed Lublin Basic Information
Table 101. Biomed Lublin BCG and Tuberculosis Vaccine Product Overview
Table 102. Biomed Lublin BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Biomed Lublin Business Overview
Table 104. Biomed Lublin Recent Developments
Table 105. Taj Pharmaceuticals Basic Information
Table 106. Taj Pharmaceuticals BCG and Tuberculosis Vaccine Product Overview
Table 107. Taj Pharmaceuticals BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Taj Pharmaceuticals Business Overview
Table 109. Taj Pharmaceuticals Recent Developments
Table 110. Ataulpho de Paiva Basic Information
Table 111. Ataulpho de Paiva BCG and Tuberculosis Vaccine Product Overview
Table 112. Ataulpho de Paiva BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Ataulpho de Paiva Business Overview
Table 114. Ataulpho de Paiva Recent Developments
Table 115. IVAC-Institute of Vaccines and Medical Biologicals Basic Information
Table 116. IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Product Overview
Table 117. IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. IVAC-Institute of Vaccines and Medical Biologicals Business Overview
Table 119. IVAC-Institute of Vaccines and Medical Biologicals Recent Developments
Table 120. Queen Saovabha Mem. Inst Basic Information
Table 121. Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Product Overview
Table 122. Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Queen Saovabha Mem. Inst Business Overview
Table 124. Queen Saovabha Mem. Inst Recent Developments
Table 125. Microgen Basic Information
Table 126. Microgen BCG and Tuberculosis Vaccine Product Overview
Table 127. Microgen BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Microgen Business Overview
Table 129. Microgen Recent Developments
Table 130. Global BCG and Tuberculosis Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 131. Global BCG and Tuberculosis Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 132. North America BCG and Tuberculosis Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 133. North America BCG and Tuberculosis Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Europe BCG and Tuberculosis Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 135. Europe BCG and Tuberculosis Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Asia Pacific BCG and Tuberculosis Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 137. Asia Pacific BCG and Tuberculosis Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America BCG and Tuberculosis Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 139. South America BCG and Tuberculosis Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Middle East and Africa BCG and Tuberculosis Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 141. Middle East and Africa BCG and Tuberculosis Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 142. Global BCG and Tuberculosis Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 143. Global BCG and Tuberculosis Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 144. Global BCG and Tuberculosis Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 145. Global BCG and Tuberculosis Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 146. Global BCG and Tuberculosis Vaccine Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of BCG and Tuberculosis Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global BCG and Tuberculosis Vaccine Market Size (M USD), 2025-2035
Figure 5. Global BCG and Tuberculosis Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global BCG and Tuberculosis Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. BCG and Tuberculosis Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global BCG and Tuberculosis Vaccine Product Life Cycle
Figure 13. BCG and Tuberculosis Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global BCG and Tuberculosis Vaccine Revenue Share by Manufacturers in 2025
Figure 15. BCG and Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market BCG and Tuberculosis Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by BCG and Tuberculosis Vaccine Revenue in 2025
Figure 18. Industry Chain Map of BCG and Tuberculosis Vaccine
Figure 19. Global BCG and Tuberculosis Vaccine Market PEST Analysis
Figure 20. Global BCG and Tuberculosis Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global BCG and Tuberculosis Vaccine Market Share by Type
Figure 27. Sales Market Share of BCG and Tuberculosis Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of BCG and Tuberculosis Vaccine by Type in 2025
Figure 29. Market Share of BCG and Tuberculosis Vaccine by Type (2020-2025)
Figure 30. Market Share of BCG and Tuberculosis Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global BCG and Tuberculosis Vaccine Market Share by Application
Figure 33. Global BCG and Tuberculosis Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global BCG and Tuberculosis Vaccine Sales Market Share by Application in 2025
Figure 35. Global BCG and Tuberculosis Vaccine Market Share by Application (2020-2025)
Figure 36. Global BCG and Tuberculosis Vaccine Market Share by Application in 2025
Figure 37. Global BCG and Tuberculosis Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global BCG and Tuberculosis Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global BCG and Tuberculosis Vaccine Market Size by Region (2020-2025)
Figure 40. North America BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America BCG and Tuberculosis Vaccine Sales Market Share by Country in 2024
Figure 43. North America BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America BCG and Tuberculosis Vaccine Market Size by Country in 2024
Figure 45. U.S. BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada BCG and Tuberculosis Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada BCG and Tuberculosis Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico BCG and Tuberculosis Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico BCG and Tuberculosis Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe BCG and Tuberculosis Vaccine Sales Market Share by Country in 2024
Figure 53. Europe BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe BCG and Tuberculosis Vaccine Market Size by Country in 2024
Figure 55. Germany BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific BCG and Tuberculosis Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific BCG and Tuberculosis Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific BCG and Tuberculosis Vaccine Market Size by Region in 2024
Figure 68. China BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America BCG and Tuberculosis Vaccine Sales and Growth Rate (K MT)
Figure 79. South America BCG and Tuberculosis Vaccine Sales Market Share by Country in 2024
Figure 80. South America BCG and Tuberculosis Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America BCG and Tuberculosis Vaccine Market Size by Country in 2024
Figure 82. Brazil BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa BCG and Tuberculosis Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa BCG and Tuberculosis Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa BCG and Tuberculosis Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa BCG and Tuberculosis Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global BCG and Tuberculosis Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America BCG and Tuberculosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe BCG and Tuberculosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan BCG and Tuberculosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China BCG and Tuberculosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global BCG and Tuberculosis Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global BCG and Tuberculosis Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global BCG and Tuberculosis Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global BCG and Tuberculosis Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global BCG and Tuberculosis Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global BCG and Tuberculosis Vaccine Market Share Forecast by Application (2026-2035)